Home / Emtricitabine, Tenofovir Disoproxil and Efavirenz / Italy
IT ATC J05AR06 · updated 2 Nov 2026
Emtricitabine, Tenofovir Disoproxil and Efavirenz shortage in Italy
Is there an Emtricitabine, Tenofovir Disoproxil and Efavirenz shortage in Italy?
Yes. As of 2 Nov 2026, 2 Emtricitabine, Tenofovir Disoproxil and Efavirenz products are reported short in Italy, the first since 5 Aug 2022. No return date has been given. Main reason: increased demand.
Also short in Canada, Belgium, New Zealand. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | EFAVIRENZ / EMTRICITABINA / TENOFOVIR DISOPROXIL ZENTIVA discontinuation | ZENTIVA K.S. | 5 Aug 2022 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | EFAVIRENZ / EMTRICITABINA / TENOFOVIR DISOPROXIL MYLAN discontinuation | MYLAN PHARMACEUTICALS LIMITED | 2 Dec 2024 | not given | Manufacturing problem Problemi produttivi |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.